STOCK TITAN

[Form 5] NutriBand Inc. Annual Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
5

NutriBand (NTRB) CFO Gerald Goodman filed a Form 5 for the fiscal year ended 01/31/2025, reporting year-end holdings and prior transactions under Section 16. The filing shows 66,085 shares of common stock beneficially owned at fiscal year-end, held directly.

Reported transactions include: acquisition of 60,085 common shares at $1.93 on 10/27/2023; a warrant at $1.93 tied to 60,085 underlying shares with an expiration date of 10/27/2026; a stock option grant for 75,000 shares at $1.93 on 03/19/2024 expiring 03/19/2027; and a stock option grant for 17,667 shares at $7.34 on 01/23/2025 expiring 01/23/2028. Ownership is indicated as direct for the securities listed.

NutriBand (NTRB) CFO Gerald Goodman ha presentato un Form 5 per l'esercizio chiuso al 31/01/2025, riportando le partecipazioni di fine esercizio e le transazioni precedenti ai sensi della Sezione 16. La dichiarazione mostra 66.085 azioni ordinarie di proprietà diretta al termine dell'esercizio.

Le transazioni riportate includono: l'acquisizione di 60.085 azioni ordinarie a 1,93 $ il 27/10/2023; una garanzia a 1,93 $ legata a 60.085 azioni sottostanti con data di scadenza 27/10/2026; una assegnazione di stock option per 75.000 azioni a 1,93 $ il 19/03/2024 con scadenza 19/03/2027; e una assegnazione di stock option per 17.667 azioni a 7,34 $ il 23/01/2025 con scadenza 23/01/2028. La proprietà è indicata come diretta per i titoli elencati.

NutriBand (NTRB) CFO Gerald Goodman presentó un Formulario 5 para el año fiscal terminado el 31/01/2025, informando participaciones al final del año y transacciones previas bajo la Sección 16. La presentación muestra 66,085 acciones ordinarias de propiedad directa al cierre del año fiscal.

Las transacciones reportadas incluyen: la adquisición de 60,085 acciones comunes a 1,93 $ el 27/10/2023; una garantía a 1,93 $ vinculada a 60,085 acciones subyacentes con fecha de vencimiento 27/10/2026; una concesión de opción sobre acciones por 75,000 acciones a 1,93 $ el 19/03/2024 con vencimiento 19/03/2027; y una concesión de opción sobre acciones por 17,667 acciones a 7,34 $ el 23/01/2025 con vencimiento 23/01/2028. La propiedad se indica como directa para los valores listados.

NutriBand(NTRB) CFO Gerald Goodman은 회계연도 말 2025년 1월 31일 종료에 대한 Form 5를 제출했으며, 섹션 16에 따라 연말 보유 및 이전 거래를 보고했습니다. 보고서에 따르면 회계연도 말에는 직접 보유된 보통주 66,085주가 있습니다.

보고된 거래에는 2023년 10월 27일에 $1.93로 60,085주를 취득한 것; 60,085주를 기초로 하는 워런트$1.93이며 만료일은 2026년 10월 27일; 2024년 3월 19일에 $1.93의 75,000주 주식매수선택권이 부여되어 2027년 3월 19일에 만료; 2025년 1월 23일에 $7.34의 17,667주 주식매수선택권이 부여되어 2028년 1월 23일에 만료됩니다. 보유는 목록에 있는 증권에 대해 직접으로 표시됩니다.

NutriBand (NTRB) CFO Gerald Goodman a déposé un Form 5 pour l’exercice se terminant le 31/01/2025, déclarant les participations de fin d’exercice et les transactions antérieures sous la Section 16. Le dépôt indique 66 085 actions ordinaires détenues directement à la fin de l’exercice.

Les transactions déclarées comprennent : l’acquisition de 60 085 actions ordinaires à 1,93 $ le 27/10/2023; une garantie à 1,93 $ liée à 60 085 actions sous-jacentes avec une date d’expiration au 27/10/2026; une attribution d’options d’achat pour 75 000 actions à 1,93 $ le 19/03/2024 expirant le 19/03/2027; et une attribution d’options d’achat pour 17 667 actions à 7,34 $ le 23/01/2025 expirant le 23/01/2028. La propriété est indiquée comme directe pour les valeurs listées.

NutriBand (NTRB) CFO Gerald Goodman hat ein Form 5 für das am 31.01.2025 endende Geschäftsjahr eingereicht und meldete Anteilseigentum am Jahresende sowie frühere Transaktionen gemäß Abschnitt 16. Die Einreichung zeigt 66.085 direkt gehaltene Stammaktien am Jahresende.

Zu den gemeldeten Transaktionen gehören: der Erwerb von 60.085 Stammaktien zu 1,93 $ am 27.10.2023; eine Warrant zu 1,93 $ gebundene 60.085 zugrunde liegende Aktien mit einer Ablaufdatum am 27.10.2026; eine Aktienoptionszuteilung über 75.000 Aktien zu 1,93 $ am 19.03.2024, Ablauf am 19.03.2027; und eine Aktienoptionszuteilung über 17.667 Aktien zu 7,34 $ am 23.01.2025, Ablauf am 23.01.2028. Das Eigentum wird für die aufgeführten Wertpapiere als direkt angegeben.

NutriBand (NTRB) المدير المالي جوراد جودمان قدم نموذج 5 للسنة المالية المنتهية في 31/01/2025، مشيرًا إلى الحيازات في نهاية السنة والمعاملات السابقة بموجب القسم 16. يظهر الإبلاغ 66,085 سهماً عادياً مملوكة بشكل مباشر في نهاية السنة المالية.

تشمل المعاملات المبلغ عنها: اكتساب 60,085 سهماً عادياً بسعر 1.93 دولار في 27/10/2023؛ ضمان عند 1.93 دولار مرتبط بـ 60,085 سهمًا أساسيًا مع تاريخ انتهاء 27/10/2026؛ منحة خيار شراء أسهم لـ 75,000 سهماً بسعر 1.93 دولار في 19/03/2024 وتنتهي 19/03/2027؛ ومنحة خيار شراء أسهم لـ 17,667 سهماً بسعر 7.34 دولار في 23/01/2025 وتنتهي 23/01/2028. تشير الملكية إلى أنها مباشرة بالنسبة للأوراق المالية المذكورة.

NutriBand (NTRB) 首席财务官 Gerald Goodman 已提交 Form 5,针对截至 2025 年 1 月 31 日的财政年度,报告了年末持有情况和依据第 16 条的此前交易。该申报显示在财政年度末有 66,085 股直接所有的普通股

报告的交易包括:在 2023/10/27 以 1.93 美元购买了 60,085 股普通股;一个与 60,085 股基础股票相关的 以 1.93 美元定价的认股权证,到期日为 2026/10/27;在 2024/03/19 授予的 75,000 股、行使价 1.93 美元的股票期权,到期日为 2027/03/19;以及在 2025/01/23 授予的 17,667 股、行使价 7.34 美元的股票期权,到期日为 2028/01/23。所列证券的所有权被标注为直接所有。

Positive
  • None.
Negative
  • None.

NutriBand (NTRB) CFO Gerald Goodman ha presentato un Form 5 per l'esercizio chiuso al 31/01/2025, riportando le partecipazioni di fine esercizio e le transazioni precedenti ai sensi della Sezione 16. La dichiarazione mostra 66.085 azioni ordinarie di proprietà diretta al termine dell'esercizio.

Le transazioni riportate includono: l'acquisizione di 60.085 azioni ordinarie a 1,93 $ il 27/10/2023; una garanzia a 1,93 $ legata a 60.085 azioni sottostanti con data di scadenza 27/10/2026; una assegnazione di stock option per 75.000 azioni a 1,93 $ il 19/03/2024 con scadenza 19/03/2027; e una assegnazione di stock option per 17.667 azioni a 7,34 $ il 23/01/2025 con scadenza 23/01/2028. La proprietà è indicata come diretta per i titoli elencati.

NutriBand (NTRB) CFO Gerald Goodman presentó un Formulario 5 para el año fiscal terminado el 31/01/2025, informando participaciones al final del año y transacciones previas bajo la Sección 16. La presentación muestra 66,085 acciones ordinarias de propiedad directa al cierre del año fiscal.

Las transacciones reportadas incluyen: la adquisición de 60,085 acciones comunes a 1,93 $ el 27/10/2023; una garantía a 1,93 $ vinculada a 60,085 acciones subyacentes con fecha de vencimiento 27/10/2026; una concesión de opción sobre acciones por 75,000 acciones a 1,93 $ el 19/03/2024 con vencimiento 19/03/2027; y una concesión de opción sobre acciones por 17,667 acciones a 7,34 $ el 23/01/2025 con vencimiento 23/01/2028. La propiedad se indica como directa para los valores listados.

NutriBand(NTRB) CFO Gerald Goodman은 회계연도 말 2025년 1월 31일 종료에 대한 Form 5를 제출했으며, 섹션 16에 따라 연말 보유 및 이전 거래를 보고했습니다. 보고서에 따르면 회계연도 말에는 직접 보유된 보통주 66,085주가 있습니다.

보고된 거래에는 2023년 10월 27일에 $1.93로 60,085주를 취득한 것; 60,085주를 기초로 하는 워런트$1.93이며 만료일은 2026년 10월 27일; 2024년 3월 19일에 $1.93의 75,000주 주식매수선택권이 부여되어 2027년 3월 19일에 만료; 2025년 1월 23일에 $7.34의 17,667주 주식매수선택권이 부여되어 2028년 1월 23일에 만료됩니다. 보유는 목록에 있는 증권에 대해 직접으로 표시됩니다.

NutriBand (NTRB) CFO Gerald Goodman a déposé un Form 5 pour l’exercice se terminant le 31/01/2025, déclarant les participations de fin d’exercice et les transactions antérieures sous la Section 16. Le dépôt indique 66 085 actions ordinaires détenues directement à la fin de l’exercice.

Les transactions déclarées comprennent : l’acquisition de 60 085 actions ordinaires à 1,93 $ le 27/10/2023; une garantie à 1,93 $ liée à 60 085 actions sous-jacentes avec une date d’expiration au 27/10/2026; une attribution d’options d’achat pour 75 000 actions à 1,93 $ le 19/03/2024 expirant le 19/03/2027; et une attribution d’options d’achat pour 17 667 actions à 7,34 $ le 23/01/2025 expirant le 23/01/2028. La propriété est indiquée comme directe pour les valeurs listées.

NutriBand (NTRB) CFO Gerald Goodman hat ein Form 5 für das am 31.01.2025 endende Geschäftsjahr eingereicht und meldete Anteilseigentum am Jahresende sowie frühere Transaktionen gemäß Abschnitt 16. Die Einreichung zeigt 66.085 direkt gehaltene Stammaktien am Jahresende.

Zu den gemeldeten Transaktionen gehören: der Erwerb von 60.085 Stammaktien zu 1,93 $ am 27.10.2023; eine Warrant zu 1,93 $ gebundene 60.085 zugrunde liegende Aktien mit einer Ablaufdatum am 27.10.2026; eine Aktienoptionszuteilung über 75.000 Aktien zu 1,93 $ am 19.03.2024, Ablauf am 19.03.2027; und eine Aktienoptionszuteilung über 17.667 Aktien zu 7,34 $ am 23.01.2025, Ablauf am 23.01.2028. Das Eigentum wird für die aufgeführten Wertpapiere als direkt angegeben.

SEC Form 5
FORM 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response: 1.0
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Form 3 Holdings Reported.
Form 4 Transactions Reported.
1. Name and Address of Reporting Person*
Goodman Gerald

(Last) (First) (Middle)
C/O NUTRIBAND INC.
121 S. ORANGE AVE, SUITE 1500

(Street)
ORLANDO FL 32801

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NutriBand Inc. [ NTRB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
01/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Amount (A) or (D) Price
Common Stock 10/27/2023 X 60,085 A $1.93 66,085 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant $1.93 06/05/2024 X 60,085 10/27/2023 10/27/2026 Common Stock 60,085 $1.93 60,085 D
Stock Option $1.93 03/19/2024 A 75,000 03/19/2024 03/19/2027 Common Stock 75,000 $1.93 75,000 D
Stock Option $7.34 01/23/2025 A 17,667 01/23/2025 01/23/2028 Common Stock 17,667 $7.34 185,500 D
Explanation of Responses:
/s/ Gerald Goodman 10/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NutriBand (NTRB) disclose in this Form 5?

The CFO reported year-end beneficial ownership and prior insider transactions, including common stock, a warrant, and stock option grants.

How many NutriBand (NTRB) shares did the CFO own at year-end?

The filing shows 66,085 common shares beneficially owned at the end of the fiscal year 01/31/2025, held directly.

What common stock transaction was reported by NTRB's CFO?

An acquisition of 60,085 common shares at $1.93 on 10/27/2023.

What derivative securities are reported for NTRB's CFO?

A warrant at $1.93 with 60,085 underlying shares expiring 10/27/2026; stock options for 75,000 shares at $1.93 expiring 03/19/2027; and 17,667 shares at $7.34 expiring 01/23/2028.

What is the reporting period for this Form 5 for NTRB?

The statement covers the issuer’s fiscal year ended 01/31/2025.

Is the ownership direct or indirect for the reported NTRB holdings?

The filing indicates direct ownership for the listed securities.
Nutriband Inc

NASDAQ:NTRB

NTRB Rankings

NTRB Latest News

NTRB Latest SEC Filings

NTRB Stock Data

87.12M
3.52M
70.78%
2.89%
1.05%
Biotechnology
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
ORLANDO